Drugdiscovery >> Clinical Trials >> News
19905
Views
Lilly’s experimental lung cancer drug successful in phase III clinical trial - drugdiscovery.com
Lilly’s experimental lung cancer drug successful in phase III clinical trial - drugdiscovery.com


Eli Lilly & Co. announced in a press release that necitumumab (IMC-11F8), in combination with gemcitabine and cisplatin, as first-line treatment for stage IV squamous cell non-small cell lung cancer (NSCLC) improved overall survival in patients, compared with standard chemotherapy.
Read More >>


Tags: Eli Lilly, necitumumab, advanced lung cancer, new drug,experimental drug, stage IV, squamous cell non-small cell lung cancer - August 13, 2013
Related Articles
4631
Views
Theravance’s experimental COPD drug meets study goal Theravance’s experimental COPD drug meets study goal
Theravance announced that the drug, named TD-408, taken as a once-per-day treatment for moderate to severe chronic obstructive pulmonary disease met its goals in a midstage clinical trial. Read More >>

Tags: Theravance, experimental drug, COPD, lung disease, clinical trial

3928
Views
GSK has ended the trials of its new lung cancer treatment GSK has ended the trials of its new lung cancer treatment
Phase 3 trial of its MAGE-A3 was reported to be finished by GlaxoSmithKline. They say it is impossible to make sure that the drug is effective against non-small-cell lung cancer. Read More >>

Tags: GSK clinical trial., MAGE-A3, lung cancer, lung cancer drug, lung cancer drug development

8038
Views
Medivir’s bone drug successful in Phase 1 clinical trial Medivir’s bone drug successful in Phase 1 clinical trial
The investigational cathepsin K inhibitor MIV-711, used as the treatment of osteoarthritis and other bone related disorders, has shown to be safe and tolerable at doses where it potently decreased car Read More >>

Tags: Medivir, cathepsin K inhibitor, MIV-711, osteoarthritis, bone, drug, invstigational, clinical trial

4761
Views
Teplizumab effective in phase 2 Teplizumab effective in phase 2
Teplizumab is an experimental drug designed to block the advance of type 1 diabetes in its earliest stages. It showed success in phase II clinical trial in patients who still had moderately healthy Read More >>

Tags: Teplizumab,experimental drug, clinical trial, type 1 diabetes, insulin, immunotherapy

7791
Views
Promising results of Reolysin in Phase 2 clinical trial in patients with squamous cell carcinoma of the lung Promising results of Reolysin in Phase 2 clinical trial in patients with squamous cell carcinoma of the lung
Oncolytics Biotech’s drug Reolysin, used in combination with carboplatin and paclitaxel, has shown high tumor shrinkage in patients with metastatic or recurrent squamous cell carcinoma of the lung Read More >>

Tags: Reolysin, clinical trial, squamous cell carcinoma of the lung, SCCLC, Oncolytics Biotech

5589
Views
Cystic fibrosis drug candidate shows positive results in Phase 1A Cystic fibrosis drug candidate shows positive results in Phase 1A
Celtaxsys’s experimental drug CTX-4430, intended for the treatment of pulmonary inflammation in CF, showed to be safe in healthy volunteers in the first of two clinical trials in Phase 1 program. Read More >>

Tags: Cystic fibrosis, CF, clinical trial, experimental drug, Celtaxys

7594
Views
Mallinckrodt's pain drug successful in Phase 3 clinical trial Mallinckrodt's pain drug successful in Phase 3 clinical trial
The experimental pain drug MNK-795 met the primary endpoint of a Phase 3 study, improving the pain scores, compared to placebo, in patients with acute pain after surgery. Read More >>

Tags: pain drug, MNK-795, clinical trial, Mallinckrodt

6852
Views
New succes on Phase II trial of a new GBM vaccine New succes on Phase II trial of a new GBM vaccine
ImmunoCellular Therapeutics Ltd's GBM vaccine proved to be successful on Phase II clinical trial. GBM is one of the most offensive cancer of the brain. There are few therapeutic options for this, so t Read More >>

Tags: GBM, Brain Cancer, ImmunoCellular Therapeutics, Ltd, Phase II. clinical trial.

5812
Views
Boehringer Ingelheim’s  COPD drug successful in  Phase 3 studies Boehringer Ingelheim’s COPD drug successful in Phase 3 studies
The results show that olodaterol Respimat, in addition to usual care, provides statistically significant improvements in lung function in patients with COPD, compared to usual care alone. Read More >>

Tags: olodaterol Respimat, COPD, drug, new treatment, Boehringer Ingelheim, Boehringer, clinical trial

13094
Views
PAT-SM6 antibody successful in Phase I/IIa clinical trial for multiple myeloma PAT-SM6 antibody successful in Phase I/IIa clinical trial for multiple myeloma
Patrys Limited has released additional clinical data for six end-stage, multi-resistant multiple myeloma patients treated with PAT-SM6. The trial is progressing to its 4th and final patient cohort. Read More >>

Tags: multiple myeloma, clinical trial, PAT-SM6, antibody, Patrys Limited, end stage

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013